Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Impact evaluation of the fire at Valmet’s Rautpohja factory site in Jyväskylä, Finland, ongoing

Valmet Oyj’s press release May 9, 2022 at 4:45 p.m. EESTThe impact evaluation of a fire that broke out on Saturday May 7 at Valmet’s Rautpohja factory site in Jyväskylä, Finland, is ongoing. The fire, which started at a workshop during a roll test and caused minor injuries to one employee, was fully extinguished over the weekend. The official investigations by the authorities are ongoing at the factory site. The majority of machine workshops at the Rautpohja factory site are unimpacted. Valmet is planning to continue production later this week in these unimpacted machine workshop areas.

Save the date 16 May - Invitation to Munters Investor Relations webinar focused on Data Centers

Welcome to Munters webinar focused on Data Centers, a prioritized growth market for Munters. The webinar will provide an overview of the market as well as Munters strategy and operations. Participants: CEO and President and acting President business area AirTech, Klas Forsström, VP Data Center Technologies, Frank Pellegrino and VP Sales Americas, Data Center Technologies, Keith Dunnavant. The webcast will start on the 16 of May at 13:00 CET (12:00 BST in London, and 07:00 ET in New York) and is estimated to end at 13:45 CET. The event will be webcasted live on Munters Investor

Aptahem enters new consortium financed by the KK Foundation

Aptahem (publ) today announce that the company enters a consortium together with Örebro University, Attgeno AB, BioReperia AB, Buzzard Pharmaceuticals AB, Lipum AB, Thermo Fisher Scientific och Toleranzia AB. The newly established consortium aims to evaluate new treatments to reduce inflammation in cardiovascular diseases and breast cancer.The joint research project, titled Drug discovery targeting inflammation – novel therapeutic aspects on vascular inflammation, thrombosis and breast cancer, has obtained financing from the Swedish KK-foundation and will run over a four-year period with

Buybacks of shares of series B in Trelleborg during week 18, 2022

During the period May 2 to May 6, 2022, Trelleborg AB (LEI code 213800XY16PAWG2PAD14) has repurchased in total 712,827 own shares of series B (ISIN: SE0000114837) as part of the buyback program initiated by the Board of Directors in order adapt the company’s capital structure and thereby contribute to increased shareholder value.   The share buybacks form part of the buyback program of a maximum of 25,272,178 shares of series B for a total maximum amount of SEK 5,000 million, which Trelleborg announced on April 27, 2022. The buyback program, which runs between April 28, 2022, to the

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions   9 May 2022 at 16.00 p.m. EESTBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Sarah van Hellenberg Hubar-Fisher Position: Member of the Board/Deputy member Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 14589/4/4 ____________________________________________ Transaction date: 2022-05-08 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions   9 May 2022 at 16.00 p.m. EESTBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Päivi Malinen Position: Member of the Board/Deputy member Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 14583/5/6 ____________________________________________ Transaction date: 2022-05-09 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Unique insights into solid-state batteries through new research collaboration

Batteries are essential to achieve a fossil-free and climate-neutral society. Solid-state batteries are considered to be the future within battery technology, although further research is necessary. A new international research project will contribute to the realisation of high-energy density solid-state batteries by studying new battery materials through combined neutron and X-ray imaging.[ANISSA researchers by ODIN control cabin at ESS] Some of the researchers of the ANISSA project by the ODIN instrument's control cabin at ESS in Lund, Sweden. Photo: Julia Öberg/ESS Tomorrow’s

Correction of press release: Missing MAR label in previous press release “RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning”

RaySearch Laboratories AB (publ) issues a correction of the press release that was sent out at 10:00 May 9, 2022. The correction refers to the fact that the press release lacked the MAR label with reference to the EU Market Abuse Regulation (MAR). The following text should have been included in the press release: This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10:00 CET on May 9, 2022. The

ASSMANN at the Clerkenwell Design Week in London

Office furniture manufacturer presents furnishing solutions and office furniture for modern working environments at international design festival in LondonAt the Clerkenwell Design Week in London, ASSMANN Office Furniture Ltd. will be presenting its diverse product portfolio for the comprehensive furnishing of innovative working environments and holistic room concepts, inviting visitors to come to its showroom on Turnmill Street from 24 to 26 May 2022. Beautifully designed furniture and inspiring room concepts will be exhibited, as well as ASSMANN 4ROOMS, the service range offering

Appointment of joint corporate brokers

9 May 2022 13:00 BST Appointment of joint corporate brokers AstraZeneca PLC announced that its joint corporate brokers will be Morgan Stanley & Co. International plc and J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove), effective as of 9 May 2022. AstraZeneca AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal &

Mandatory notification of trade – Shares for employees 2022

Employees in more than 20 countries have been offered the opportunity to buy Orkla shares at a discount, for the amount of NOK 10 000, NOK 15 000 or NOK 30 000 (included the discount). The purchase price will be set at Orkla's closing price on 13 May 2022, minus 15% discount.The offer is valid from 9 – 13 May 2022. This programme was introduced in 1999. Please see the attachment for an overview of the primary insiders who have ordered shares in Orkla on 9 May 2022. The purchase price and the number of shares acquired by the primary insiders, as well as their updated shareholdings,

Corem initiates repurchase of own shares

In accordance with a decision at the Annual General Meeting on 27 April 2022, Corem Property Group AB (publ) will initiate a buyback program of its own shares. Purchase of own shares may take place on one or more occasions during the period until the next Annual General Meeting.At the Annual General Meeting the Board was authorized, until the next Annual General Meeting, to decide on acquiring the company’s own shares. Acquisitions may take place of at most the number of shares so that after each acquisition the group’s total holding of its own shares amounts to at most ten per cent of

Scientific article about the advantageous S2-based protein secretion system ExpreS2 and a moderate-throughput research variant called FAS2FURIOUS

Hørsholm, Denmark, May 9, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Frontiers in Bioengineering and Biotechnology published an article about the ability of S2 cells to express challenging targets.Excerpts: “…FAS2FURIOUS is comparable in effort to simple E. coli systems and allows users to clone and test up to 46 constructs in just 2 weeks. Given the ability of S2 cells to express challenging targets, including receptor ectodomains, secreted glycoproteins, and viral antigens, FAS2FURIOUS represents an attractive orthogonal

Power production in April 22.9 GWh

Weaker winds than normal in April resulted in a power production of 22.9 GWh, compared to the month’s budget of 26.9 GWh. Halmstad, 9 May 2022 ARISE AB (publ) For further information, please contact: Per-Erik Eriksson, CEO Arise AB, +46 702 409 902 This information is information that Arise AB is obliged to make public pursuant to the EU MarketAbuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 13.05 CEST on 9 May, 2022. Regarding information about how we process your personal data we refer to our

Recent study from Japan confirms the value of original GastroPanel® biomarkers diagnosis of autoimmune atrophic gastritis.

Biohit Oyj press release  9.5.2022 at 14.00 local time (EEST)   The publisher of the topmost medical journal Nature (1) reported recently a study that evaluated the accuracy of serological testing for the biomarkers (pepsinogens and gastrin) in diagnosis of autoimmune atrophic gastritis (AAG) (1). This cross-sectional study provides results that are similar as recently reported by Biohit partners in a population-based screening setting, where GastroPanel® showed unrivalled test characteristics in non-invasive screening of asymptomatic healthy people for AAG (2).     AAG is

Invitation to presentation of Movinn’s report for Q1 2022

Company Announcement nr. 13 - 2022Press Release9 May 2022 13.00 (CEST)  Copenhagen, Denmark - Movinn A/S published its interim report for Q1 2022 on Thursday 5 May 2022 .On Tuesday 10 May there will be held two seperate web conferences.  Web Conference 1 w/ HC Andersen Capital at 12.30 CEST, the company will hold a web conference hosted by analyst and digital IR provier H.C. Andersen Capital with the attendance of CEO Patrick Blok. After the presentation there will be a Q&A session. The web conference will be held in English. You can join the conference by computer or

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release May 9, 2022 at 1:40 p.m. Nokian Tyres has received an announcement from JPMorgan Chase & Co. on May 6, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the indirect holding in Nokian Tyres shares owned by the funds and accounts managed by JPMorgan Chase & Co. fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on May 4, 2022. The indirect shareholding of the funds and accounts managed by JPMorgan Chase & Co. in Nokian Tyres

Zalaris receives SAP Recognized Expertise 2022 for Talent Management

SAP has recognised Zalaris' exceptional expertise and extensive project experience with the SAP Recognized Expertise for Talent Management in Germany.To obtain the title of SAP Recognized Expertise, an SAP Partner must meet various demanding examination criteria. The award confirms that Zalaris' consultants are professionally trained and certified and have implemented a large number of successful projects in the field of talent management. This recognition also documents that customers rate Zalaris’ project performance positively. As a SAP Gold Partner, Zalaris offers a wide range of

Productive hotspot for the food industry

Anuga FoodTec in Cologne is the most important source of impetus for the international food and beverage industry. As the world's most important supplier fair, it covers all aspects of food production and after two years of pandemic, the hotspot was back in business the last week of April. Lesjöfors’ experts of metal conveyor belts for the food industry were there.The Dutch Lesjöfors company Tribelt that specializes in the manufacture of metal conveyor belts for the food industry, participated with a stand at the fair. We asked Henri Veldhuis, MD of Tribelt a couple of questions about the

Premix signs $79.9 million contract for a new production facility in the U.S.

The major agreement will help secure critical diagnostic supplies in the United States and better serve Premix’s global customers.     Gastonia / Helsinki, May 9, 2022 – The U.S. Department of Defense, working with the Department of Health and Human Services, awarded a $79.9 million contract to Premix, Inc. to establish a plastic compound manufacturing plant in North Carolina. The facility will primarily produce plastic materials for diagnostic testing. The facility will be built in Gaston County, centrally located in the growing region of advanced manufacturing in the southeast U.

Hexagon Purus Maritime receives inaugural order for hydrogen cylinders for maritime applications

Hexagon Purus Maritime, a wholly owned subsidiary of Hexagon Purus, has received its inaugural order for cylinders to be used in onboard storage of hydrogen in maritime vessels. Hexagon Purus’ type 4 hydrogen cylinders will be used in onboard swappable storage containers for maritime vessels operating in the inland waterways in Europe. The value of the order is approximately EUR 1.1 million (approx. NOK 11 million). Driving Energy Transformation “Our Type 4 high-pressure cylinders are at the core of what we do and with their corrosion resistance and long lifetime, the cylinders enable

Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and Denise Goode

Lund, Sweden, May 9, 2022 - Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces the appointment of Staffan Encrantz and Denise Goode as members of the company's Board of Directors. Mr. Encrantz is the founder and Chairman of Allegro Investment Fund, a $750 million fund which has been investing in companies across a number of industries for 30 years and is also a major shareholder in Alligator Bioscience. Ms. Goode has more than 25 years of experience in business leadership and innovation, having held a number of senior executive and board-level positions in the pharmaceutical and

ChemoTech supports a Ukrainian hospital by selling an IQwave™ at a discounted price

After ChemoTech recently received a direct request for help from Ulis Hospital in Ukraine, the Company of course agreed to sell an IQwave™ to the hospital at a heavily discounted price.The registration of ChemoTech's TSE system, also known as IQwave 3.0 CE, began in autumn 2021 in Ukraine. This process was completed just before Russia's invasion of the country began.   During the spring, the Company had ongoing contact with the distributor, who already had a complete launch strategy that had to be suspended due to the current war. Ulis Hospital played a central role in the distributor'

There are no items matching the current filter
There are no more items matching the current filter
Back to top